In the dynamic world of pharmaceutical development, the availability of high-quality intermediates is paramount. One such critical compound is 3-Amino-2-pyrazinecarboxylic Acid (CAS 5424-01-1). This versatile molecule has gained significant attention, particularly for its indispensable role in the synthesis of Favipiravir, a broad-spectrum antiviral drug that has been at the forefront of combating viral outbreaks, including COVID-19.

As a leading pharmaceutical intermediate manufacturer based in China, we understand the urgency and precision required in supplying compounds like 3-Amino-2-pyrazinecarboxylic Acid. Our commitment is to provide a product with high purity (typically 98% min), ensuring that our clients, whether they are R&D scientists or procurement managers, can rely on its consistent performance in their synthesis pathways. The journey from raw material to a life-saving medication is complex, and having a dependable supplier for key building blocks like this pyrazine derivative is essential for maintaining production timelines and product efficacy.

The synthesis of Favipiravir involves intricate chemical reactions where 3-Amino-2-pyrazinecarboxylic Acid serves as a foundational component. It is transformed through several steps to yield crucial intermediates, ultimately leading to the final active pharmaceutical ingredient (API). The demand for such antiviral agents underscores the importance of a stable and accessible supply chain for their precursors. When you choose to buy 3-Amino-2-pyrazinecarboxylic Acid from us, you are not just purchasing a chemical; you are securing a vital link in the chain of global health solutions. We offer competitive pricing and readily available samples, making it easier for you to initiate trials and scale up production. Our goal as a manufacturer is to empower pharmaceutical companies worldwide with the materials they need for innovation and to meet public health demands. Explore how our reliable supply and attractive price points can support your manufacturing needs for this critical pharmaceutical intermediate.